Why Every AI Lab Will Become a Biotech Company | Andrew Huberman
Huberman envisions AI labs expanding into biotech, with tools that read and influence the nervous system, while emphasizing the challenges of precise, safe stimulation. He also discusses emerging ways to measure brain and autonomic activity, alongside shifts toward manipulating specific neurons. His outlook includes broader use of whole-body MRI and a health technology cycle in which attention-seeking activity gives way to more useful and accessible tools.
Preview · 20 more points in the app
Read the Full SummaryKey Takeaways
Huberman predicts Meta, OpenAI, and Anthropic will become biotech companies, with noninvasive brain reading and writing among their goals; he welcomes engineers entering neuroscience but cautions that the brain is far more complicated than a computer.
Huberman says future nervous-system tools would need to control stimulation with spatial and temporal precision and adjust its intensity, a difficult task because neural signals are graded rather than simply on or off. He notes that ultrasound and transcranial magnetic stimulation are being explored, but their spatial control is currently limited.
Huberman envisions AI learning how an individual's neural activity maps to a desired state and dynamically adjusting noninvasive stimulation; he compares this with a sleep device that changes temperature to influence sleep. He also speculates that such stimulation could extend from sleep applications to eyeglasses that shift focus or relaxation.
Huberman describes direct autonomic monitoring as a step beyond estimating stress, recovery, and sleep mainly from heart rate and HRV: a cuff in development would relate daily activities, speech, and breathing to distress or eustress. He also predicts eyeglasses could use pupil-size changes to measure focus.
TECHNOLOGY
“I'll go on record saying this…”—
“Everyone knows about eye masks to get the darkness out…”—
“You could imagine like within 12 months to a year of the release of the technology that I just described, you could imagine somebody developing eyeglasses like this that are…”—
Intro
The host asks how talented founders can sustain the energy required to build ambitious companies. Huberman argues that sleep needs vary, self-assessment matters, and sustainable performance depends on matching work and recovery to physiology.
Building Energy for High Performance
Huberman explains that sleep requires quieting thought, lowering heart rate, and loosening awareness of body position. He describes sensory attention, long exhales, rocking, and emerging eye-stimulation masks as ways to support sleep.
How to Fall Asleep
Huberman criticizes attention-driven health optimization and predicts that public health education will become less theatrical, then attract more credible researchers and clinicians who communicate useful science.
What’s Gone Wrong With Health Optimization
Huberman predicts major AI firms will expand into biotech, aiming to read and write to the nervous system non-invasively. He emphasizes the unresolved challenge of precise, graded, and safe neural stimulation.
AI Companies Could Become Biotech Companies
Huberman discusses implantable and wearable stimulation, including vagus-nerve devices, and weighs their potential benefits against invasiveness, safeguards, and limited precision.
Implantable Devices
Huberman describes how memory experiments challenge assumptions about precise neural firing sequences, while overlapping neuron functions complicate attempts to manipulate memories and behaviors.
Memory
Huberman imagines future tools that measure and influence brain states, while stressing that researchers still lack a strong account of thought, waking states, and how neural activity supports them.
Controlling Your Brain
Huberman traces the shift from broad interventions toward precise neural control and explains how genetic tags, stimulation, and AI could enable targeted manipulation, while noting major safety and ethical concerns.
Genetic Engineering
Huberman recounts the controversial editing of human embryos and considers how genetic screening and selection could evolve, arguing that these developments demand serious scrutiny and open discussion.
The Key to Meaningful Success
Huberman says matching work to genuine curiosity is central to meaningful success, recalling his adviser’s encouragement and arguing that useful health technologies will follow the current attention-heavy phase.
Related Episodes
Important Disclaimers
Not Investment Advice: For education only — not financial, tax or legal advice.
AI-Generated: Made by AI from source transcripts and may contain errors.
No Guarantees: Past performance does not predict future results; investing carries risk.
Our Commentary · Request Removal